LoadingLoadingLoadingNet selling: insiders sold $4.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $200K to $500K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Sells/Trims (3)
Millennium
$75.2M
trimmed
Squarepoint
$71.3M
trimmed
Two Sigma
$66.9M
trimmed
Buys (1)
Sells (2)
No tracked top-trader positions in DXCM as of Oct 21, 16:47 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.61 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 21, 2026
EPS expected
$0.63 to $0.72
Revenue expected
25 analysts
Last 30 days
Split both ways
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $0.70 / $0.61Yahoo Finance | +15.11% beat | $1.31B No estimate | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $0.56 / $0.47Yahoo Finance | +18.99% beat | $1.19B No estimate | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | $0.68 / $0.65Yahoo Finance | +4.50% beat | $1.26B No estimate | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $0.61 / $0.57Yahoo Finance | +7.51% beat | $1.21B No estimate | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $0.48 / $0.44Alpha Vantage | +9.09% beat | $1.16B No estimate | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $0.32 / $0.33Alpha Vantage | -3.03% miss | $1.04B No estimate | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | $0.45 / $0.50Alpha Vantage | -10.00% miss | $1.11B No estimate | Unavailable |
| Sep 30, 2024 | Oct 24, 2024 | $0.45 / $0.43Alpha Vantage | +4.65% beat | $994.2M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.21B | $1.26B | $1.19B | $1.31B |
| Cost of what it sold | $477.9M | $466.9M | $441.6M | $478.4M |
| Gross profit | $731.4M | $792.7M | $750.3M | $830.0M |
| What it spent | ||||
| Research and development | $157.5M | $148.2M | $145.3M | $153.0M |
| Sales and admin | $331.4M | $321.5M | $349.7M | $358.7M |
| Total operating expenses | $488.9M | $469.7M | $495.0M | $511.7M |
| What was left | ||||
| Operating profit | $242.5M | $323.0M | $255.3M | $318.3M |
| Interest on debt | $4.7M | $4.2M | $3.1M | $3.0M |
| Profit before tax | $352.3M | $340.7M | $269.5M | $317.5M |
| Tax | $68.5M | $73.4M | $70.0M | $68.4M |
| Net profit | $283.8M | $267.3M | $199.5M | $249.1M |
| EBITDA | $420.6M | $410.1M | $339.7M | $388.7M |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Form 4 DexCom Inc: Michael Jon Brown (EVP Chief Legal Compliance Off) For: 15 October By Investing.com
NeutralOct 19Form 4 DexCom Inc: Michael Jon Brown (EVP Chief Legal Compliance Off) For: 15 October
NeutralOct 19Form 4 DEXCOM INC For: Oct 15 Filed by: Brown Michael Jon
NeutralOct 19At $85.48 a share, DexCom (DXCM) officer Michael Jon Brown sells 1,700 shares.
Leans bearishOct 19Dexcom class action lawsuits claim ShinyHunters stole health data
BearishOct 18IDEXX Laboratories, Inc. (IDXX) Stock forecasts
Leans bullishOct 18Insulet stock stood at USD 141.10 on October 16, 2026, 60.24 percent below 52-week high
NeutralOct 17Insulet stock stood at USD 141.10 on October 16, 2026, 60.24 percent below 52-week high
NeutralOct 17
